Table 2.
Focus Group Participant Characteristics
| Breast/Ovarian Cancers (n = 66) | Gynecologic Cancers (n = 44) | Lung/Head/ Neck/Oral Cancers (n = 88) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Risk | High | Average | High | Average | High | Average | Total | ||
| # of Focus Groups | 6 | 6 | 4 | 4 | 8 | 8 | 36 | ||
| # of Participants | n=33 % (n) | n=33 % (n) | n=21 % (n) | n=23 % (n) | n=47 % (n) | n=41 % (n) | 198 % (n) | ||
| Sex | |||||||||
| Male | — | — | — | — | 48.9% (23) | 41.5% (17) | 20.2% (40) | ||
| Female | 100.0% (33) | 100.0% (33) | 100.0% (21) | 100.0% (23) | 51.1% (24) | 58.5% (24) | 79.8% (158) | ||
| Age | |||||||||
| Mean (range) | 35.9 (30, 43) | 51.1 (45, 58) | 35.6 (30, 44) | 51.4 (45, 60) | 34.0 (30, 39) | 34.3 (30, 39) | 57.2 (50, 69) | 55.3 (48, 68) | 47.0 (30, 69) |
| Race/Ethnicity | |||||||||
| White | 72.7% (24) | 69.7% (23) | 52.4% (11) | 73.9% (17) | 87.2% (41) | 61.0% (25) | 71.2% (141) | ||
| Black | 21.2% (7) | 15.2% (5) | 23.8% (5) | 8.7% (2) | 8.5% (4) | 22.0% (9) | 16.2% (32) | ||
| Hispanic | 3.0% (1) | 6.1% (2) | 14.3% (3) | 8.7% (2) | 4.3% (2) | 4.9% (2) | 6.1% (12) | ||
| Asian | 3.0% (1) | 3.0% (1) | — | 8.7% (2) | — | 7.3% (3) | 3.0% (6) | ||
| Other/ Mixed |
— | 6.1% (2) | 9.5% (2) | — | — | 4.9% (2) | 3.0% (6) | ||